Reversal of symptomatic hyperprolactinemia by aripiprazole [2]

American Journal of Psychiatry

Volumn 162, Issue 8, 2005, Pages 1542-1543

  Wahl, Rebecca ^a   Ostroff, Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; DOPAMINE RECEPTOR; NEUROLEPTIC AGENT; RISPERIDONE;

ADOLESCENT; BREAST CANCER; CASE REPORT; DRUG INDUCED DISEASE; ENDOCRINE DISEASE; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERPROLACTINEMIA; LETTER; OSTEOPOROSIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RECEPTOR AFFINITY; SCHIZOPHRENIA; SIDE EFFECT;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERPROLACTINEMIA; INJECTIONS, INTRAMUSCULAR; PIPERAZINES; QUINOLONES; RISPERIDONE; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 23344432626     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Wang PS, Walker AM, Tsuang MT, Orav EJ, Glynn RJ, Levin R, Avorn J: Dopamine antagonists and the development of breast cancer. Arch Gen Psychiatry 2002; 59:1147-1154
2. Kane JM, Carson WH, Saha A, McQuade RD, Ingenito G, Zimbroff DL, Ali MW: Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 2002; 63:763-771
3. Keck PE Jr, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G (Aripiprazole Study Group): A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry 2003; 160:1651-1658
4. Kapur S, Langlois X, Vinken P, Megens AA, De Coster R, Andrews JS: The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain barrier disposition: a pharmacological analysis in rats. J Pharmacol Exp Ther 2002; 302:1129-1134
5. Grunder G, Carlsson A, Wong DF: Mechanism of new antipsychotic medications: occupancy is not just antagonism. Arch Gen Psychiatry 2003; 60:974-977
6. Findling RL, Kusumakar V, Daneman D, Moshang T, De Smedt G, Binder C: Prolactin levels during long-term risperidone treatment in children and adolescents. J Clin Psychiatry 2003; 64:1362-1369